21-hydroxylase def |
Autosomal Recessive, CYP21A2
|
Ambiguous |
Absent |
Normal |
Ovary |
Severe adrenal insufficiency in infancy ± salt loss; moderate to severe androgenization at birth |
Decreased cortisol and/or mineralocorticoids. |
|
|
|
|
|
|
|
Increased 17-hydroxyprogesterone, 21-deoxycortisol, androstenedione, testosterone, and/or plasma renin (activity) |
11β-hydroxylase def |
Autosomal Recessive, CYP11B1
|
Ambiguous |
Absent |
Normal |
Ovary |
Adrenal insufficiency in infancy; moderate to severe androgenization at birth; arterial hypertension often developing at different ages |
Decreased cortisol, corticosterone, aldosterone, and/or plasma renin (activity) |
|
|
|
|
|
|
|
Increased 11-deoxycortisol, 11-deoxycorticosterone, androstenedione, testosterone |
3β-hydroxysteroid dehydrogenase II def |
Autosomal Recessive, HSD3B2
|
Commonly clitoromegaly or mild virilization, also normal |
Absent |
Normal |
Ovary |
Severe adrenal insufficiency in infancy ± salt loss, androgenization during childhood and puberty, premature pubarche |
Increased concentrations of Δ5 C21- and C19- steroids, 17 hydroxypregnenolone and DHEA suppressible by dexamethasone |
P450 oxidoreductase def |
Autosomal Recessive, POR
|
Ambiguous or normal female |
Absent |
Normal |
Ovary |
Variable androgenization at birth and puberty, glucocorticoid deficiency, features of skeletal malformations. |
Combined P450c17 and P450c21 insufficient, normal or low cortisol with poor response to ACTH stimulation, elevated 17-hydroxyprogesterone, testosterone, progesterone and corticosterone; low oestradiol. |
|
|
|
|
|
|
Maternal androgenization during pregnancy onset second trimester possible |
|
P450 aromatase def |
Autosomal Recessive, CYP19A1
|
Ambiguous |
Absent |
Normal |
Ovary |
Delayed bone age, development of ovarian cysts during infancy, childhood and puberty. Maternal androgenization during pregnancy |
High androgens in cord blood, androgens may stay elevated or normalize soon after birth |